Engineering collismycin biosynthesis enables potent acetylcholinesterase inhibitors
Year: 2026
Type: article
Abstract: Collismycins suffer from limited structural diversity that restricts bioactivity exploration. Herein, we develop a bio-chemo-relay strategy combining biosynthetic engineering and chemical diversification to construct diverse collismycin analogues, affording a potent acetylcholinesterase inhibitor 4h with superior activity to galantamine.
Source: Chemical Communications
DOI: 10.1039/d6cc05733k
Language: English
Subfield: Applied Microbiology and Biotechnology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: green
Awards: G9001345028, G9001348848, G9001354033
OpenAlex ID: W7223197484
